Altimmune, Inc. appointed Jerry Durso as Chairman of the board while developing therapeutics for MASH.
3 reports, 2 independent
Updated Aug 5
Gone quiet
- Reports
- 3
- Developments
- 1
- Repetition
- 67%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Altimmune, Inc. appointed Jerry Durso as Chairman of the board while developing therapeutics for MASH.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Altimmune, Inc.
American biopharmaceutical company
-
Mash
Japanese singer-songwriter
Nothing else this week.
Coverage
Newest first; wire copies grouped- manilatimes.net
- GlobeNewswireAltimmune Board of Directors Appoints Jerry Durso as Chairman Appointment recognizes Mr. Durso’s extensive commercial expertise as Altimmune prepares for Phase 3 development of pemvidutide in MASH Mi
- Unknown outlet